Sort
48,018 grants matching “immunotherapy”
Uncoupling pleiotropy in the LIGHT/HVEM/LTBetaR signaling network
$418,750Aaron Michael Ring · Yale University · DP5 · FY2018 · OD
Mechanisms and consequences of antigen-dependent T cell homing for adoptive immunotherapies
$418,750Jordan S Pober · Yale University · R01 · FY2025 · AI
Gene circuits programming IL-17 production in innate lymphocytes
$418,750Joonsoo Kang · Univ Of Massachusetts Med Sch Worcester · R01 · FY2016 · AI
Uncoupling pleiotropy in the LIGHT/HVEM/LTBetaR signaling network
$418,750Aaron Michael Ring · Yale University · DP5 · FY2017 · OD
Mechanisms and consequences of antigen-dependent T cell homing for adoptive immunotherapies
$418,750Jordan S Pober · Yale University · R01 · FY2023 · AI
Gene circuits programming IL-17 production in innate lymphocytes
$418,750Joonsoo Kang · Univ Of Massachusetts Med Sch Worcester · R01 · FY2015 · AI
Elucidation of the role of 2 novel cross presentation genes
$418,750Kenneth L Rock · Univ Of Massachusetts Med Sch Worcester · R01 · FY2016 · AI
Mechanisms of autoantibody production in myasthenia gravis
$418,750Kevin C O'Connor · Yale University · R01 · FY2020 · AI
Toward understanding the role of altered glycosylation in cancer
$418,750Stacy Alyse Malaker · Yale University · R35 · FY2025 · GM
Elucidation of the role of 2 novel cross presentation genes
$418,750Kenneth L Rock · Univ Of Massachusetts Med Sch Worcester · R01 · FY2020 · AI
T-Cell Responses Predict Influenza Risk in Older Adults
$418,738Janet E. McElhaney · University Of Connecticut Sch Of Med/Dnt · R01 · FY2006 · AI
Role of immune cell OGR1 in prostate cancer development and the mechanisms involv
$418,724Yan Xu · Indiana University Indianapolis · R01 · FY2011 · CA
Advanced research training in immunology for surgery trainees (ARTIST)
$418,689Ginny L Bumgardner · Ohio State University · T32 · FY2024 · AI
Expression of recombinant Fc receptors by engineered NK cells to enhance cancer cell killing
$418,599Bruce K Walcheck · University Of Minnesota · R01 · FY2024 · CA
HSP90 AS A TARGET FOR MECHANISM-BASED THERAPY FOR CASTRATION-RESISTANT PROSTATE C
$418,592Neal Rosen · Sloan-Kettering Inst Can Research · P50 · FY2008 · CA
NanoOptogenetic immunotherapy for B cell lymphoma
$418,557Gang Han · Univ Of Massachusetts Med Sch Worcester · R01 · FY2022 · CA
Rewired Metabolism and Immunosuppression in MYCN-driven Neuroblastoma
$418,553Eveline Barbieri · Baylor College Of Medicine · R01 · FY2025 · CA
Molecular and Cellular Mechanisms of Tolerance to Combined Organ and Hematopoietic Cell Transplantation after TLI and ATS/ATG Conditioning
$418,548Edgar G. Engleman · Stanford University · P01 · FY2017 · HL
Platelets-Mediated Delivery of Checkpoint Inhibitors for Post-Surgical Cancer Immunotherapy
$418,528Zhen Gu · University Of California Los Angeles · R01 · FY2019 · CA
Leveraging Zika virus and the immune system to treat glioblastoma
$418,485Milan Girish Chheda · Washington University · R01 · FY2024 · NS
Cell migration and virological synapse formation in parenteral HIV transmission
$418,451Benjamin K Chen · Icahn School Of Medicine At Mount Sinai · R01 · FY2017 · DA
HIV-1 gp120 induced CTL chemorepulsion:dysregulation of migration & localization
$418,400Mark Coleman Poznansky · Massachusetts General Hospital · R01 · FY2007 · AI
Combining AD epitope vaccine with innate immunity
$418,393University Of California Irvine · R01 · FY2004 · NS
Improving multiple sclerosis patient quality of life using microneedle patches to simplify delivery of MS drugs
$418,385Christopher M Jewell · Univ Of Maryland, College Park · R01 · FY2019 · AI
Protective Role of Nonclassical Monocytes in Immunotherapies for Solid Cancers
$418,320Catherine C Hedrick · La Jolla Institute For Immunology · U01 · FY2018 · CA